Showing results (151-160 of 209) with videos related to
Sort By:
Pageof 21
Cancer Management and Research|August 27, 2021
The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder CancerDanijel Sikic, Helge Taubert, Johannes Breyer, et al.Hepatology (Baltimore, Md.)|March 12, 2021
The Co-mutational Spectrum Determines the Therapeutic Response in Murine FGFR2 Fusion-Driven CholangiocarcinomaGajanan Kendre, Silke Marhenke, Georgina Lorz, et al.Breast Cancer Research and Treatment|May 26, 2016
Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistryRalph M Wirtz, Harri Sihto, Jorma Isola, et al.International Journal of Molecular Sciences|October 14, 2020
Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of KRT5, KRT20, and ERBB2 in Muscle-Invasive Bladder Cancer Treated by Adjuvant ChemotherapyThorsten H Ecke, Adisch Kiani, Thorsten Schlomm, et al.Breast Cancer Research and Treatment|March 11, 2011
Prognostic utility of β-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) studyGeorge Pentheroudakis, Anna Batistatou, Konstantine T Kalogeras, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2011
Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) StudyA Psyrri, K T Kalogeras, R Kronenwett, et al.Journal of Clinical Medicine|April 8, 2020
FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical CystectomyDanijel Sikic, Markus Eckstein, Ralph M Wirtz, et al.Endocrine-Related Cancer|August 14, 2009
Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissueSilvia Darb-Esfahani, Ralph M Wirtz, Bruno V Sinn, et al.Breast Cancer Research and Treatment|August 1, 2008
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trialGeorge Pentheroudakis, Konstantine T Kalogeras, Ralph M Wirtz, et al.Cancer Chemotherapy and Pharmacology|October 26, 2012
Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trialK Pliarchopoulou, K T Kalogeras, R Kronenwett, et al.Pageof 21